- Home
- MLTX vs USAC Comparison
MLTX vs USAC Comparison
Compare MLTX & USAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- USAC
- Stock Information
- Founded
- MLTX 2021
- USAC 1998
- Country
- MLTX Switzerland
- USAC United States
- Employees
- MLTX N/A
- USAC N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- USAC Natural Gas Distribution
- Sector
- MLTX Health Care
- USAC Utilities
- Exchange
- MLTX Nasdaq
- USAC Nasdaq
- Market Cap
- MLTX 2.3B
- USAC N/A
- IPO Year
- MLTX N/A
- USAC N/A
- Fundamental
- Price
- MLTX $39.74
- USAC $23.55
- Analyst Decision
- MLTX Strong Buy
- USAC Hold
- Analyst Count
- MLTX 8
- USAC 4
- Target Price
- MLTX $80.50
- USAC $26.00
- AVG Volume (30 Days)
- MLTX 425.4K
- USAC 156.1K
- Earning Date
- MLTX 05-20-2025
- USAC 05-06-2025
- Dividend Yield
- MLTX N/A
- USAC 8.92%
- EPS Growth
- MLTX N/A
- USAC 67.81
- EPS
- MLTX N/A
- USAC 0.67
- Revenue
- MLTX N/A
- USAC $966,407,000.00
- Revenue This Year
- MLTX $103.42
- USAC $6.58
- Revenue Next Year
- MLTX N/A
- USAC $4.74
- P/E Ratio
- MLTX N/A
- USAC $35.09
- Revenue Growth
- MLTX N/A
- USAC 10.03
- 52 Week Low
- MLTX $31.42
- USAC $21.06
- 52 Week High
- MLTX $58.26
- USAC $30.10
- Technical
- Relative Strength Index (RSI)
- MLTX 51.51
- USAC 40.94
- Support Level
- MLTX $39.86
- USAC $22.80
- Resistance Level
- MLTX $42.90
- USAC $24.96
- Average True Range (ATR)
- MLTX 2.15
- USAC 0.76
- MACD
- MLTX 0.03
- USAC -0.12
- Stochastic Oscillator
- MLTX 48.60
- USAC 25.77
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.